Development and application of a quality evaluation scale for ERAS health education in gynecologic malignancies - Takeaways - MDSpire

Development and application of a quality evaluation scale for ERAS health education in gynecologic malignancies

  • By

  • Jianmin Feng

  • Lu Wang

  • Hanlin Yang

  • Weijie Tian

  • Yuan Gong

  • Yan Zhu

  • Dan Zi

  • June 30, 2026

  • 0 min

Share

  • 1

    A quality evaluation scale for ERAS health education in gynecologic malignancies was developed to assess clinical health education quality management.

  • 2

    The scale includes 4 primary dimensions, 22 secondary indicators, and 36 tertiary items, covering various education stages.

  • 3

    Reliability testing showed a Cronbach’s α of 0.890 and test-retest ICC of 0.925, indicating good reliability and validity.

  • 4

    Discharge education was identified as the weakest domain, with specific items scoring below 70% in patient education.

  • 5

    The tool complements existing ERAS compliance audits, aiming to enhance patient understanding and adherence to ERAS measures.

Original Source(s)

Development and application of a quality evaluation scale for ERAS health education in gynecologic malignancies

  • by Jianmin Feng, Lu Wang, Hanlin Yang, Weijie Tian, Yuan Gong, Yan Zhu, Dan Zi

  • June 30, 2026

Related Content

Mixed adenoneuroendocrine carcinoma of the gallbladder: a case report and literature review

Diagnostic performance and clinical utility of shear-wave elastography in musculoskeletal soft-tissue tumors: a systematic review

Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report